Interaction of swainsonine with lymphoid and highly perfused tissues: a pharmacokinetics explanation for sustained immunomodulation.

MLA

Bowen, D., et al. “Interaction of Swainsonine with Lymphoid and Highly Perfused Tissues: A Pharmacokinetics Explanation for Sustained Immunomodulation.” Anticancer Research, vol. 17, no. 6D, Nov. 1997, pp. 4345–46. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9494531&authtype=sso&custid=ns315887.

APA

Bowen, D., Southerland, W. M., Bowen, C. D., & Hughes, D. E. (1997). Interaction of swainsonine with lymphoid and highly perfused tissues: a pharmacokinetics explanation for sustained immunomodulation. Anticancer Research, 17(6D), 4345–4346.

Chicago

Bowen, D, W M Southerland, C D Bowen, and D E Hughes. 1997. “Interaction of Swainsonine with Lymphoid and Highly Perfused Tissues: A Pharmacokinetics Explanation for Sustained Immunomodulation.” Anticancer Research 17 (6D): 4345–46. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9494531&authtype=sso&custid=ns315887.